These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17066142)

  • 1. Drug-induced hyperprolactinemia.
    Bandyopadhyay P
    Timely Top Med Cardiovasc Dis; 2006 May; 10():E14. PubMed ID: 17066142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced hyperprolactinemia.
    Bandyopadhyay P
    Drugs Today (Barc); 2006 Feb; 42(2):103-19. PubMed ID: 16541187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology insight: measuring prolactin in clinical samples.
    Smith TP; Kavanagh L; Healy ML; McKenna TJ
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):279-89. PubMed ID: 17315036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent hyperprolactinemia following mammoplasty: a rare association.
    Marino A; Patel T; Whitten E; Peiris AN
    Tenn Med; 2009 Jul; 102(7):47-8. PubMed ID: 19634649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
    Byerly M; Suppes T; Tran QV; Baker RA
    J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia and prolactinomas.
    Mancini T; Casanueva FF; Giustina A
    Endocrinol Metab Clin North Am; 2008 Mar; 37(1):67-99, viii. PubMed ID: 18226731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
    Poyraz BC; Aksoy C; Balcioğlu I
    Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipituitary antibodies in idiopathic hyperprolactinemic patients.
    De Bellis A; Colao A; Pivonello R; Savoia A; Battaglia M; Ruocco G; Tirelli G; Lombardi G; Bellastella A; Bizzarro A
    Ann N Y Acad Sci; 2007 Jun; 1107():129-35. PubMed ID: 17804540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sex hormones on bone metabolism of the otic capsule--an overview.
    Horner KC
    Hear Res; 2009 Jun; 252(1-2):56-60. PubMed ID: 19121641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
    Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D
    Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
    Kopecek M; Bares M; Horacek J; Mohr P
    Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antipsychotic-induced symptomatic hyperprolactinemia: clinical consequences and therapeutic strategies].
    Pollice R; Di Giovambattista E; Tomassini A; Di Pucchio A; Ussorio D; Roncone R; Casacchia M
    Clin Ter; 2007; 158(2):173-9. PubMed ID: 17566521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.
    Zadrozna-Sliwka B; Bolanowski M; Jawiarczyk A; Kaluzny M; Syrycka J
    Neuro Endocrinol Lett; 2008 Feb; 29(1):178-84. PubMed ID: 18283239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour.
    Messina G; Lissoni P; Brivio F; Rovelli F; Fumagalli L; Bartolacelli E; Mazza U; Colombo E; Bertoglio A
    In Vivo; 2008; 22(6):845-8. PubMed ID: 19181018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.